HCW Biologics
HCWB
8 hedge funds and large institutions have $512K invested in HCW Biologics in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$199K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$164K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$93.6K |
| 4 |
Goldman Sachs
New York
|
+$86.3K |
| 5 |
BlackRock
New York
|
+$71.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $145K | +$199K | +189 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $119K | +$164K | +156 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $68K | +$93.6K | +89 | New |
|
|
4
Goldman Sachs
New York
| $63K | +$86.3K | +82 | New |
|
|
5
BlackRock
New York
| $52K | +$71.5K | +68 | New |
|
6
HighTower Advisors
Chicago,
Illinois
| $45K | +$61K | +58 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $18K | +$25.2K | +24 | New |
|
8
Morgan Stanley
New York
| $2K | +$2.1K | +2 | New |
|
HCWB Hedge Fund Activity: Q3 2021 in Review
8 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q3 2021, worth a combined $512K.
Buyers outnumbered sellers: 8 funds opened new HCWB positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $199K.
- 8 institutional investors held HCW Biologics (HCWB) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $512K of HCW Biologics stock for Q3 2021.
- 8 funds opened new HCW Biologics positions in Q3 2021 and 0 closed out, a net change of +8 holders.
- The largest HCW Biologics buyer in Q3 2021 was Millennium Management, an estimated $199K added.
Based on aggregated 13F filings for Q3 2021.